Medtronic PLC vs NIO Inc. — how do they compare? Medtronic PLC trades at $88.79 (market cap $112.24B), while NIO Inc. trades at $3.58 (market cap $8.62B). The key difference: Medtronic PLC is far larger — about 13× NIO Inc.'s market cap, and Medtronic PLC pays a 3.28% dividend while NIO Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and NIO Inc. for 81 Days on average.
| MDT | NIO | |
|---|---|---|
Market Cap | $112.24B | $8.62B |
Volume | 105,663,236 | 39,648,517 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.35 | $7.46 |
52-Week Low | $73.75 | $3.37 |
Typical Hold Time | 63 Days | 81 Days |
Enterprise Value | $131.58B | $6.52B |
Dividend Yield | 3.28% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $88.48, up 3.47% today, with a bullish analyst consensus and a $97.80 price target. The stock shows strong fundamentals with revenue growth to $33.54B in 2025 and a net income margin of 13.93%. Recent earnings beats and a 49-year dividend growth streak highlight operational strength, though technical indicators signal a near-term bearish trend with key support at $87.
MDT presents a compelling long-term investment with stable profitability and dividend reliability, but faces risks from debt increases and competitive pressures. Upside potential exists if the company maintains earnings momentum and executes on growth initiatives, while volatility may persist due to market sentiment shifts.
NIO trades at $3.58, up 1.13% in the last session but near a 52-week low amid a bearish technical trend. The company reported Q3 2026 deliveries up 25.4% and recently formed a strategic battery-swap partnership with Geely, yet it continues to post net losses with a -4.17% net margin. Analyst consensus is a 'Buy' with a $6.23 price target, but high debt and negative cash flows pose challenges.
The outlook remains cautious; revenue growth and partnership potential offer upside, but persistent losses, cash burn, and intense EV competition present significant risks. Investors should weigh the long-term battery-swap network expansion against near-term financial instability and market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →